These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 26683142)

  • 21. Translational Research in Vitiligo.
    Katz EL; Harris JE
    Front Immunol; 2021; 12():624517. PubMed ID: 33737930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting Innate Immunity to Combat Cutaneous Stress: The Vitiligo Perspective.
    Boniface K; Passeron T; Seneschal J; Tulic MK
    Front Immunol; 2021; 12():613056. PubMed ID: 33936032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The genetics of pediatric cutaneous autoimmunity: The sister diseases vitiligo and alopecia areata.
    Silverberg N
    Clin Dermatol; 2022; 40(4):363-373. PubMed ID: 35183681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vitiligo Pathogenesis and Emerging Treatments.
    Rashighi M; Harris JE
    Dermatol Clin; 2017 Apr; 35(2):257-265. PubMed ID: 28317534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frontiers and controversies in the pathobiology of vitiligo: separating the wheat from the chaff.
    Boissy RE; Spritz RA
    Exp Dermatol; 2009 Jul; 18(7):583-5. PubMed ID: 19320739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Review of the etiopathomechanism of vitiligo: a convergence theory.
    Le Poole IC; Das PK; van den Wijngaard RM; Bos JD; Westerhof W
    Exp Dermatol; 1993 Aug; 2(4):145-53. PubMed ID: 8162332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vitiligo, reactive oxygen species and T-cells.
    Glassman SJ
    Clin Sci (Lond); 2011 Feb; 120(3):99-120. PubMed ID: 20958268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vitiligo.
    Picardo M; Dell'Anna ML; Ezzedine K; Hamzavi I; Harris JE; Parsad D; Taieb A
    Nat Rev Dis Primers; 2015 Jun; 1():15011. PubMed ID: 27189851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune mechanisms in vitiligo.
    Bystryn JC
    Immunol Ser; 1989; 46():447-73. PubMed ID: 2488866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunopathogenesis of vitiligo.
    Sandoval-Cruz M; García-Carrasco M; Sánchez-Porras R; Mendoza-Pinto C; Jiménez-Hernández M; Munguía-Realpozo P; Ruiz-Argüelles A
    Autoimmun Rev; 2011 Oct; 10(12):762-5. PubMed ID: 21334464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MHC class II super-enhancer increases surface expression of HLA-DR and HLA-DQ and affects cytokine production in autoimmune vitiligo.
    Cavalli G; Hayashi M; Jin Y; Yorgov D; Santorico SA; Holcomb C; Rastrou M; Erlich H; Tengesdal IW; Dagna L; Neff CP; Palmer BE; Spritz RA; Dinarello CA
    Proc Natl Acad Sci U S A; 2016 Feb; 113(5):1363-8. PubMed ID: 26787888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Possible roles of B lymphocyte activating factor of the tumour necrosis factor family in vitiligo autoimmunity.
    Lin X; Tian H; Xianmin M
    Med Hypotheses; 2011 Mar; 76(3):339-42. PubMed ID: 21075543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Role of Oxidative Stress in Vitiligo: An Update on Its Pathogenesis and Therapeutic Implications.
    Chang WL; Ko CH
    Cells; 2023 Mar; 12(6):. PubMed ID: 36980277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mitochondrial DNA acquires immunogenicity on exposure to nitrosative stress in patients with vitiligo.
    Al-Shobaili HA; Rasheed Z
    Hum Immunol; 2014 Oct; 75(10):1053-61. PubMed ID: 25218915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. T cells in the control of organ-specific autoimmunity.
    Bluestone JA; Bour-Jordan H; Cheng M; Anderson M
    J Clin Invest; 2015 Jun; 125(6):2250-60. PubMed ID: 25985270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Features, Immunopathogenesis, and Therapeutic Strategies in Vitiligo.
    Wang Y; Li S; Li C
    Clin Rev Allergy Immunol; 2021 Dec; 61(3):299-323. PubMed ID: 34283349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The genetics of generalized vitiligo and associated autoimmune diseases.
    Spritz RA
    J Dermatol Sci; 2006 Jan; 41(1):3-10. PubMed ID: 16289692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients.
    van den Boorn JG; Konijnenberg D; Dellemijn TA; van der Veen JP; Bos JD; Melief CJ; Vyth-Dreese FA; Luiten RM
    J Invest Dermatol; 2009 Sep; 129(9):2220-32. PubMed ID: 19242513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Humoral and cellular autoimmunity in genuine vitiligo studied by means of an antigen produced from melanoma cells].
    Höfs T
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(2):244-50. PubMed ID: 6179826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Innate immune activation and thyroid autoimmunity.
    Kawashima A; Tanigawa K; Akama T; Yoshihara A; Ishii N; Suzuki K
    J Clin Endocrinol Metab; 2011 Dec; 96(12):3661-71. PubMed ID: 21956420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.